LakeShore Biopharma Co. L...

NASDAQ: LSB · Real-Time Price · USD
0.79
-0.03 (-3.66%)
At close: Aug 20, 2025, 10:19 AM

LakeShore Biopharma Ltd Cash Flow Statement

Financials in CNY. Fiscal year is April - March.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Net Income
-99.98M -433.46M -145.48M -545.73K -191.83M
Depreciation & Amortization
36.65M 42.19M 36.69M 31.15M 27.91M
Stock-Based Compensation
13.56M 9.79M 3.5M 7.76M 76.76M
Other Working Capital
-13.34M 39.23M -6.45M -64.05K -44.29K
Other Non-Cash Items
48.49M 153.78M 4.42M -3.45K 2.23M
Deferred Income Tax
-4.31M -21.73M 1.13M 4.94M 17.45M
Change in Working Capital
-115.38M -45.79M -92.75M -64.05K -186.68M
Operating Cash Flow
-120.98M -295.23M -182.47M -613.23K -246.61M
Capital Expenditures
-17.86M -44.25M -57.05M -298.93M -104.88M
Cash Acquisitions
n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a -200M n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a
Other Investing Acitivies
-4.3M n/a n/a n/a n/a
Investing Cash Flow
-17.01M -44.25M -56.98M -200M -104.24M
Debt Repayment
-3.58M -78.93M 100.88M 364.56M 8.26M
Common Stock Repurchased
n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 284.2M 216.57M -163.06M n/a
Financial Cash Flow
-3.58M 205.26M 317.45M 201.5M 739.26M
Net Cash Flow
-139.07M -123.82M 99.3M -389.57M 388.41M
Free Cash Flow
-138.84M -339.48M -239.52M -299.55M -351.49M